Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (361)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Serplulimab	Anti-PD-1 mAb	Both (Solid & Hematologic)
Molecule Serplulimab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Zimberelimab	Anti-PD-1 mAb	Both (Solid & Hematologic)
Molecule Zimberelimab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Retifanlimab	Anti-PD-1 mAb	Both (Solid & Hematologic)
Molecule Retifanlimab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Envafolimab	Anti-PD-1 mAb	Both (Solid & Hematologic)
Molecule Envafolimab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Balstilimab	Anti-PD-1 mAb	Both (Solid & Hematologic)
Molecule Balstilimab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Pucotenlimab	Anti-PD-1 mAb	Both (Solid & Hematologic)
Molecule Pucotenlimab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Adebrelimab	Anti-PD-1 mAb	Both (Solid & Hematologic)
Molecule Adebrelimab Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Idasanutlin	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Idasanutlin Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Navtemadlin	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Navtemadlin Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Brigimadlin	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Brigimadlin Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Siremadlin	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Siremadlin Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Milademetan	MDM2 Inhibitor	Both (Solid & Hematologic)
Molecule Milademetan Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor

Serplulimab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Zimberelimab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Retifanlimab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Envafolimab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Balstilimab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Pucotenlimab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Adebrelimab Immunotherapy (Checkpoint Inhibitor)
Therapeutic Category Immunotherapy (Checkpoint Inhibitor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Anti-PD-1 mAb
Idasanutlin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Navtemadlin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Brigimadlin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Siremadlin Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor
Milademetan Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism MDM2 Inhibitor

‹ 1 … 13 14 15 16 17 … 31 ›

Product Range

Company

Global Network

Products

Serplulimab

Zimberelimab

Retifanlimab

Envafolimab

Balstilimab

Pucotenlimab

Adebrelimab

Idasanutlin

Navtemadlin

Brigimadlin

Siremadlin

Milademetan

Serplulimab

Zimberelimab

Retifanlimab

Envafolimab

Balstilimab

Pucotenlimab

Adebrelimab

Idasanutlin

Navtemadlin

Brigimadlin

Siremadlin

Milademetan